Legend Drugs And Formulations Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 15-12-2024
- Paid Up Capital ₹ 6.23 Cr
as on 15-12-2024
- Company Age 31 Year, 5 Months
- Last Filing with ROC 31 Mar 2011
- Open Charges ₹ 39.13 Cr
as on 15-12-2024
- Satisfied Charges ₹ 3.90 Cr
as on 15-12-2024
About Legend Drugs And Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 6.23 Cr.
The company currently has active open charges totaling ₹39.13 Cr. The company has closed loans amounting to ₹3.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Suvarchala Yerramilli, Ketan Pandya, and Yerramilli Raju serve as directors at the Company.
- CIN/LLPIN
U24230TG1993PTC015906
- Company No.
015906
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jun 1993
- Date of AGM
29 Sep 2011
- Date of Balance Sheet
31 Mar 2011
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Legend Drugs And Formulations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ketan Pandya  | Nominee Director | 19-Mar-2011 | Current |
| Suvarchala Yerramilli | Director | 01-Apr-2008 | Current |
| Yerramilli Raju | Director | 01-Apr-2008 | Current |
Financial Performance of Legend Drugs And Formulations.
Enhance accessibility to Legend Drugs And Formulations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Legend Drugs And Formulations?
Unlock access to Legend Drugs And Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Endoven Pharmaceuticals Private LimitedActive 26 years 6 monthsSuvarchala Yerramilli and Yerramilli Raju are mutual person
- Shruthi Infraprojects Private LimitedActive 16 years 10 months
Suvarchala Yerramilli and Yerramilli Raju are mutual person
- Leela Ventures (India) Private LimitedActive 19 years 3 months
Suvarchala Yerramilli and Yerramilli Raju are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 19 Nov 2008 | ₹16.75 Cr | Open |
Union Bank Of India Creation Date: 30 Jun 2008 | ₹2.25 Cr | Open |
Union Bank Of India Creation Date: 10 Apr 2008 | ₹15.50 Cr | Open |
How Many Employees Work at Legend Drugs And Formulations?
Unlock and access historical data on people associated with Legend Drugs And Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Legend Drugs And Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Legend Drugs And Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
